Antiviral peptide nanocomplexes as a potential antiviral therapeutic modality for HIV/HCV co-infection

It is estimated that 4 to 5 million people are currently co-infected with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). HIV/HCV co-infection is associated with unique health risks including increased hepatotoxicity of antiretrovirals, accelerated progression of HCV and liver diseas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Jingjin, Mulvenon, Andrea, Makarov, Edward, Wagoner, Jill, Knibbe, Jaclyn, Kim, Jong Oh, Osna, Natalia, Bronich, Tatiana K., Poluektova, Larisa Y.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602242/
https://ncbi.nlm.nih.gov/pubmed/23403120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2013.01.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars